50 participants
Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-09-10
- Start Date:
- 2015-07-31
- Completion:
- 2020-06-30
Conditions
- Borderline Resectable Pancreatic Cancer
Interventions
- DRUG
No Results Yet